At LogicBio, we are committed to delivering genetic medicine to pediatric patients with rare diseases.
We are initially targeting rare liver disorders where it is critically important to treat patients early in life, before irreversible damage occurs. We believe our foundational platform technology, GeneRide, is well-suited to this goal because – unlike traditional gene therapy – it harnesses the cell’s natural DNA repa...
At LogicBio, we are committed to delivering genetic medicine to pediatric patients with rare diseases.
We are initially targeting rare liver disorders where it is critically important to treat patients early in life, before irreversible damage occurs. We believe our foundational platform technology, GeneRide, is well-suited to this goal because – unlike traditional gene therapy – it harnesses the cell’s natural DNA repair process to integrate a corrective gene directly into the patient’s chromosomes. This approach is designed to provide a durable therapeutic benefit from a single treatment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.